144 related articles for article (PubMed ID: 11348411)
21. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.
White J; Levine A; Gustafson G; Wimbish K; Ingold J; Pettinga J; Matter R; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):791-7. PubMed ID: 7860390
[TBL] [Abstract][Full Text] [Related]
22. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning.
King TA; Cederbom GJ; Champaign JL; Smetherman DH; Bolton JS; Farr GH; McKinnon WM; Kuske RR; Fuhrman GM
Am J Surg; 1998 Dec; 176(6):497-501. PubMed ID: 9926778
[TBL] [Abstract][Full Text] [Related]
23. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
24. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
Mirza NQ; Vlastos G; Meric F; Sahin AA; Singletary SE; Newman LA; Kuerer HM; Ames FC; Ross MI; Feig BW; Pollock RE; Buchholz TA; McNeese MD; Strom EA; Hortobagyi GN; Hunt KK
Ann Surg Oncol; 2000 Oct; 7(9):656-64. PubMed ID: 11034242
[TBL] [Abstract][Full Text] [Related]
25. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy.
Kini VR; Vicini FA; Frazier R; Victor SJ; Wimbish K; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):341-6. PubMed ID: 10030259
[TBL] [Abstract][Full Text] [Related]
26. Local recurrence of breast cancer after skin-sparing mastectomy following core needle biopsy: case reports and review of the literature.
Uriburu JL; Vuoto HD; Cogorno L; Isetta JA; Candas G; Imach GC; Bernabo OL
Breast J; 2006; 12(3):194-8. PubMed ID: 16684314
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of breast-conserving therapy for younger women with breast cancer.
Guenther JM; Kirgan DM; Giuliano AE
Arch Surg; 1996 Jun; 131(6):632-6. PubMed ID: 8645070
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
Mestak O; Hromadkova V; Fajfrova M; Molitor M; Mestak J
Ann Surg Oncol; 2016 Mar; 23(3):776-81. PubMed ID: 26467459
[TBL] [Abstract][Full Text] [Related]
29. Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?
Adkisson CD; Bagaria SP; Parker AS; Bray JM; Gibson T; Thomas CS; Heckman MG; McLaughlin SA
Ann Surg Oncol; 2012 Apr; 19(4):1129-36. PubMed ID: 21975859
[TBL] [Abstract][Full Text] [Related]
30. [Minimal invasive surgery in clinically occult breast carcinoma].
Winzer KJ; Madeja C; Guski H; Filimonow S; Hamm B; Müller JM
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1215-8. PubMed ID: 9574382
[TBL] [Abstract][Full Text] [Related]
31. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.
Wazer DE; Jabro G; Ruthazer R; Schmid C; Safaii H; Schmidt-Ullrich RK
Radiat Oncol Investig; 1999; 7(2):111-7. PubMed ID: 10333252
[TBL] [Abstract][Full Text] [Related]
32. Preliminary results: double lumpectomies for multicentric breast carcinoma.
Kapoor NS; Chung A; Huynh K; Giuliano AE
Am Surg; 2012 Dec; 78(12):1345-8. PubMed ID: 23265123
[TBL] [Abstract][Full Text] [Related]
33. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities.
White RR; Halperin TJ; Olson JA; Soo MS; Bentley RC; Seigler HF
Ann Surg; 2001 Jun; 233(6):769-77. PubMed ID: 11371735
[TBL] [Abstract][Full Text] [Related]
34. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
[TBL] [Abstract][Full Text] [Related]
35. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ
Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250
[TBL] [Abstract][Full Text] [Related]
36. The effect of surgery type on survival and recurrence in very young women with breast cancer.
Quan ML; Paszat LF; Fernandes KA; Sutradhar R; McCready DR; Rakovitch E; Warner E; Wright FC; Hodgson N; Brackstone M; Baxter NN
J Surg Oncol; 2017 Feb; 115(2):122-130. PubMed ID: 28054348
[TBL] [Abstract][Full Text] [Related]
37. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
38. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
Subhedar P; Olcese C; Patil S; Morrow M; Van Zee KJ
Ann Surg Oncol; 2015 Oct; 22(10):3273-81. PubMed ID: 26215193
[TBL] [Abstract][Full Text] [Related]
39. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
40. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
